Clincosm LogoSign in Get a demo

neurofibromatosis type 1

Showing 1 - 25 of 63
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FARD (RaDiCo Cohort) (RaDiCo-FARD)

Recruiting
  • Inherited Epidermolysis Bullosa
  • +8 more
    • Bobigny, France
    • +14 more
    Jul 18, 2023

    Neurofibromatosis Type 1, Plexiform Neurofibromas, Post-operative Trial in Beijing, Shanghai (Selumetinib, Placebo)

    Not yet recruiting
    • Neurofibromatosis Type 1
    • +2 more
    • Beijing, China
    • +2 more
    Apr 11, 2023

    Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

    Recruiting
    • Diffuse Astrocytoma
    • +22 more
    • Phoenix, Arizona
    • +26 more
    Jan 27, 2023

    Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma Trial in Canada, Puerto Rico, United States (Carboplatin,

    Recruiting
    • Low Grade Glioma
    • +2 more
    • Birmingham, Alabama
    • +120 more
    Jan 27, 2023

    Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma Trial in

    Active, not recruiting
    Has Results
    • Neurofibromatosis Type 1
    • +2 more
    • Birmingham, Alabama
    • +125 more
    Jan 25, 2023

    Data Collected From Individuals Administered Neurobehavioral

    Enrolling by invitation
    • HIV
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Biology of Skin Neurofibromas in Neurofibromatosis Type 1

      Completed
      • Neurofibromatosis Type 1
      • Neurofibroma
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 20, 2023

        US Selumetinib Registry

        Not yet recruiting
        • Neurofibromatosis Type 1
        • Plexiform Neurofibromas
          • (no location specified)
          Jan 5, 2023

          PASS of Paediatric Patients Initiating Selumetinib

          Recruiting
          • Neurofibromatosis Type 1
            • Angers, France
            • +3 more
            Jan 12, 2023

            Neurofibromatosis Type 1 Trial in Worldwide (Selumetinib)

            Active, not recruiting
            • Neurofibromatosis Type 1
            • Rochester, Minnesota
            • +8 more
            Nov 10, 2022

            Cutaneous Neurofibromas in People With NF1

            Recruiting
            • Neurofibromatosis Type 1
            • +3 more
            • Evaluation of the natural history of cutaneous neurofibromas
            • Baltimore, Maryland
              Johns Hopkins University
            Oct 12, 2022

            Frameshift Peptides of Children With NF1

            Completed
            • Neurofibromatosis Type 1
            • Frameshift Array blood sample test
            • Washington, District of Columbia
            • +2 more
            Aug 29, 2022

            Neurofibromatosis 1, Neurofibromatosis Type 1, NF1 Trial run by the National Cancer Institute (NCI) (AZD6244)

            Active, not recruiting
            • Neurofibromatosis 1
            • +3 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Aug 24, 2022

            Neurofibromatosis Type 1 Trial in Worldwide (Selumetinib granule formulation, Selumetinib capsule formulation)

            Recruiting
            • Neurofibromatosis Type 1
            • Selumetinib granule formulation
            • Selumetinib capsule formulation
            • Phoenix, Arizona
            • +17 more
            Aug 4, 2022

            Neurofibromatosis Type 1 Trial in Los Angeles (Whole-body Magnetic Resonance Imaging)

            Recruiting
            • Neurofibromatosis Type 1
            • Whole-body Magnetic Resonance Imaging
            • Los Angeles, California
              Cedars Sinai Medical Center
            Jul 11, 2022

            Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1, Recurrent Malignant Peripheral Nerve Sheath Tumor

            Recruiting
            • Metastatic Malignant Peripheral Nerve Sheath Tumor
            • +2 more
            • Computed Tomography
            • +4 more
            • Rochester, Minnesota
              Mayo Clinic
            Jul 6, 2022

            Neurofibromatosis Type 1 Trial in Japan (Selumetinib)

            Active, not recruiting
            • Neurofibromatosis Type 1
            • Minato-ku, Japan
            • +3 more
            Jun 9, 2022

            Familial Investigations of Childhood Cancer Predisposition

            Recruiting
            • Acute Leukemia
            • +45 more
              • Memphis, Tennessee
                St. Jude Children's Research Hospital
              May 11, 2022

              Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

              Completed
              • Neurofibromatosis Type 1
              • +4 more
              • Laboratory Biomarker Analysis
              • +2 more
              • Los Angeles, California
              • +11 more
              Apr 22, 2022

              Neurofibromatosis 1, NF1, Neurofibromatosis Type 1 Trial in Chicago

              Recruiting
              • Neurofibromatosis 1
              • +2 more
                • Chicago, Illinois
                  Ann & Robert H. Lurie Children's Hospital of Chicago
                Mar 11, 2022

                Stem Cells in NF1 Tumors of the Central Nervous System

                Suspended
                • Neurofibromatosis Type 1
                • Tumors of the Central Nervous System
                • Collection of Stem Cells
                • Washington, District of Columbia
                  Children's National Medical Center
                Mar 8, 2022

                Neurofibromatosis Type 1 Trial in Washington (CogmedRM, Mobymax)

                Completed
                • Neurofibromatosis Type 1
                • CogmedRM
                • Mobymax
                • Washington, District of Columbia
                  Children's National Health System
                Mar 2, 2022

                Measures in Neurofibromatosis 1: Test- Retest

                Suspended
                • Neurofibromatosis Type 1
                • Outcome measures
                • London, United Kingdom
                  Guy's Hospital
                Dec 23, 2021

                Molecular Aspects of Preimplantation Genetic Diagnosis for NF1

                Recruiting
                • Neurofibromatosis Type 1
                  • Strasbourg, France
                    Service Laboratoire de Diagnostic Génétique - Hôpitaux Universit
                  Nov 24, 2021

                  Neurofibromatosis Type 1, Plexiform Neurofibroma Trial in United States (Binimetinib)

                  Active, not recruiting
                  • Neurofibromatosis Type 1
                  • Plexiform Neurofibroma
                  • Birmingham, Alabama
                  • +21 more
                  Dec 4, 2021